دورية أكاديمية
Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
| العنوان: | Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma |
|---|---|
| المؤلفون: | Anna Klimaszewska-Wiśniewska, Izabela Neska-Długosz, Karolina Buchholz, Justyna Durślewicz, Dariusz Grzanka, Anna Kasperska, Paulina Antosik, Jan Zabrzyński, Alina Grzanka, Maciej Gagat |
| المصدر: | Cancers, Vol 13, Iss 12, p 3017 (2021) |
| بيانات النشر: | MDPI AG, 2021. |
| سنة النشر: | 2021 |
| المجموعة: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| مصطلحات موضوعية: | pancreatic adenocarcinoma, prognostic factor, KIF11, KIF14, cell division, genomic instability, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| الوصف: | Available biomarkers for pancreatic adenocarcinoma (PAC) are inadequate to guide individual patient prognosis or therapy. Therefore, herein we aimed to verify the hypothesis that differences in the expression of KIF11 and KIF14, i.e., molecular motor proteins being primarily implicated in cell division events could account for the differences in the clinical outcome of PAC patients. In-house immunohistochemistry was used to evaluate the protein expressions of KIF11 and KIF14 in PAC, whereas RNA-seq datasets providing transcript expression data were obtained from public sources. IHC and mRNA results were correlated with clinicopathological features and overall survival (OS). Furthermore, the genes co-expressed with KIF11 or KIF14 were predicted and functionally annotated. In our series, malignant ducts displayed more intense but less abundant KIF11 staining than normal-appearing ducts. The former was also true for KIF14, whereas the prevalence of positive staining was similar in tumor and normal adjacent tissues. Based on categorical immunoreactive scores, we found KIF11 and KIF14 to be frequently downregulated or upregulated in PAC cases, respectively, and those with elevated levels of either protein, or both together, were associated with better prognosis. Specifically, we provide the first evidence that KIF11 or KIF14 proteins can robustly discriminate between patients with better and worse OS, independently of other relevant clinical risk factors. In turn, mRNA levels of KIF11 and KIF14 were markedly elevated in tumor tissues compared to normal tissues, and this coincided with adverse prognosis, even after adjusting for multiple confounders. Tumors with low predicted KIF11 or KIF14 expression were seen to have enrichment for circadian clock, whereas those with high levels were enriched for the genomic instability-related gene set. KIF11 and KIF14 were strongly correlated with one another, and CEP55, ASPM, and GAMT were identified as the main hub genes. Importantly, the combined expression of these five genes emerged as the most powerful independent prognostic indicator associated with poor survival outcome compared to classical clinicopathological factors and any marker alone. In conclusion, our study identifies novel prognostic biomarkers for PAC, which await validation. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 13123017 2072-6694 |
| العلاقة: | https://www.mdpi.com/2072-6694/13/12/3017Test; https://doaj.org/toc/2072-6694Test |
| DOI: | 10.3390/cancers13123017 |
| الوصول الحر: | https://doaj.org/article/014fa12f9f4c46209edc770ac3b8319eTest |
| رقم الانضمام: | edsdoj.014fa12f9f4c46209edc770ac3b8319e |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 13123017 20726694 |
|---|---|
| DOI: | 10.3390/cancers13123017 |